摘要
目的:观察应用奥曲肽联合凝血酶治疗肝硬化合并上消化道出血的效果。方法:2018年收治肝硬化合并上消化道出血患者80例,随机分为两组,各40例。对照组采用药物奥曲肽药物治疗;观察组采用奥曲肽联合凝血酶药物治疗。比较两组治疗效果。结果:观察组治疗总有效率优于对照组,不良反应率低于对照组,临床指标显著优于对照组,差异有统计学意义(P<0.05)。结论:肝硬化合并上消化道出血应用奥曲肽联合凝血酶治疗方式在提高患者的治疗有效率、降低不良反应发生率和优化临床指标方面具有较好的效果。
Objective:To observe the effect of octreotide combined with thrombin in the treatment of liver cirrhosis with upper gastrointestinal hemorrhage.Methods:In 2018,80 patients with cirrhosis and upper gastrointestinal hemorrhage were admitted,they were randomly divided into the two groups with 40 cases in each group.The control group was treated with octreotide.The observation group was treated with octreotide and thrombin.The therapeutic effects of the two groups were compared.Results:The total effective rate of treatment in the observation group was better than that in the control group,and the adverse reaction rate was lower than that in the control group,the differences were statistically significant(P<0.05).Conclusion:The combination of octreotide and thrombin in the treatment of liver cirrhosis with upper gastrointestinal hemorrhage has a good effect in improving the treatment efficiency,reducing the incidence of adverse reactions and optimizing the clinical indicators.
作者
贺卫华
He Weihua(Traditional Chinese Medicine Hospital of Changning City,Hunan Province,Hunan Changning 421500)
出处
《中国社区医师》
2020年第17期24-24,26,共2页
Chinese Community Doctors
关键词
奥曲肽
凝血酶
肝硬化
上消化道出血
Octreotide
Thrombin
Cirrhosis
Upper gastrointestinal hemorrhage